Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of na&#xef;ve and treated eyes

Macular Diseases

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Surv Ophthalmol

Couturier A, Wykoff CC, Lupidi M, Udaondo P, Peto T, Pintard PJ

doi: 10.1016/j.survophthal.2025.04.004

Macular Diseases

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

J Clin Med

Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest

doi: 10.3390/jcm13237336

Macular DiseasesRetinal Diseases

Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review

Surv Ophthalmol

Nanji K, Hatamnejad A, Grad J, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Zeraatkar D, Singh R, Munk MR, Sadda SR, Sarraf D, Kaiser P, Guymer R, Sivaprasad S, Fraser-Bell S, Tham YC, Garg SJ, Wong TY, Wykoff CC, Chaudhary V

doi: 10.1016/j.survophthal.2025.09.009

Macular DiseasesRetinal Diseases

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

Ophthalmol Ther

Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network

doi: 10.1007/s40123-025-01252-6

Macular Diseases

Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series

BMC Ophthalmol

Bantounou MA, Elsheikh M, Ijasan A, Santiago C

doi: 10.1186/s12886-025-03953-9

Macular DiseasesRetinal Diseases

Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Ophthalmology

Nanji K, Grad J, Hatamnejad A, El-Sayes A, Mihalache A, Gemae M, Huang R, Phillips M, Kaiser PK, Munk MR, Garg SJ, Sarraf D, Sadda SR, Fraser-Bell S, Zeraatkar D, Ma J, Borrelli E, Steel DH, Sivaprasad S, Wykoff CC, Chaudhary V

doi: 10.1016/j.ophtha.2025.07.038

Macular Diseases

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

JAMA Ophthalmol

Khan MA, Hill L, Stoilov I, Haller JA

doi: 10.1001/jamaophthalmol.2024.6371

Macular DiseasesRetinal Diseases

Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting

Ophthalmol Ther

Borselli M, Elfalah M, Trunfio TA, Scala A, Chisari D, Mancini A, Lucisano A, Carnovale-Scalzo G, Mollace V, Improta G, Zweifel S, Scorcia V, Toro MD, Carnevali A

doi: 10.1007/s40123-025-01232-w

Macular Diseases

Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE

Ophthalmol Retina

Goldberg RA, Mar FA, Csaky K, Amador M, Khanani AM, Gibson K, Kolomeyer AM, Sim DA, Murata T, Wang T, Udaondo P, Souverain A, Shildkrot YE, Vujosevic S, Nudleman E, Sivaprasad S

doi: 10.1016/j.oret.2024.11.015

Related content

Anatomic biomarkers as potential endpoints in diabetic macular edema: Systematic literature review with identification of macular volume as a key surrogate for visual acuity

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

Visual outcomes associated with optical coherence tomography biomarkers in diabetic macular edema: A systematic review

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series

Baseline Optical Coherence Tomography Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-Analysis

Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting

Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE